Skip to content

Clinical trials

Phase 2 Pulmonary Fibrosis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Phase 2 Country / region: Canada Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20101
20111
20131
20171
20201
20211
20221
20231
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated4
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Celgene2
Endeavor Biomedicines, Inc.2
Amgen1
Avalyn Pharma Inc.1
Bristol-Myers Squibb1
Centocor, Inc.1
Contineum Therapeutics1
Kyntra Bio1
Mannkind Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis14
Idiopathic Pulmonary Fibrosis11
Lung Diseases, Interstitial6
Fibrosis3
Idiopathic Interstitial Pneumonias3
Alveolitis, Extrinsic Allergic1
Lung Diseases1
Pathologic Processes1
Respiratory Tract Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.